4-Bromo-2-fluoro-N-methylbenzamide is an intermediate in the synthesis of MDV 3100 , is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex.